Viatris Specialty
1 products tracked · names used in filings: Viatris Specialty
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 28 Jul 2026🇺🇸 FDA approval
FDA approves Gwyn Lo (ethinyl estradiol, norelgestromin): new formulation or manufacturer
Viatris Specialty; NDA219990; New formulation or manufacturer; system · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Gwyn Lo ethinyl estradiol, norelgestromin | Approved | 2026-07-28 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.